Cargando…
Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
The anti-inflammatory role of regulatory B cells (Breg cells) has been associated with IL-35 based on studies of experimental autoimmune uveitis and encephalitis. The role of Breg cells and IL-35(+) Breg cells for type 1 diabetes (T1D) remains to be investigated. We studied PBMCs from T1D subjects a...
Autores principales: | Luo, Zhengkang, Lundin, Sara, Mejia-Cordova, Mariela, Hassani, Imane, Blixt, Martin, Hjelmqvist, Daisy, Lau, Joey, Espes, Daniel, Carlsson, Per-Ola, Sandler, Stellan, Singh, Kailash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657454/ https://www.ncbi.nlm.nih.gov/pubmed/34884797 http://dx.doi.org/10.3390/ijms222312988 |
Ejemplares similares
-
Kinetics of immune cell responses in the multiple low‐dose streptozotocin mouse model of type 1 diabetes
por: Luo, Zhengkang, et al.
Publicado: (2019) -
Interleukin-35 administration counteracts established murine type 1 diabetes – possible involvement of regulatory T cells
por: Singh, Kailash, et al.
Publicado: (2015) -
Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas
por: Li, Xiujuan, et al.
Publicado: (2018) -
The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control
por: Singh, Kailash, et al.
Publicado: (2017) -
Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes
por: Espes, Daniel, et al.
Publicado: (2013)